Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for NBIX

Stock NameNeurocrine Biosciences Inc
TickerNBIX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS64125C1099
LEI549300FECER0XBN49756

Show aggregate NBIX holdings

News associated with NBIX

Canaccord Genuity Group Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $160.00
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price raised by Canaccord Genuity Group from $158.00 to $160.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also recently commented on NBIX. Needham & Company LLC raised shares of Neurocrine Biosciences from […] - 2025-05-09 08:37:11
Neurocrine Biosciences (NASDAQ:NBIX) Shares Gap Up on Analyst Upgrade
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) shares gapped up prior to trading on Tuesday after Royal Bank of Canada raised their price target on the stock from $137.00 to $145.00. The stock had previously closed at $109.75, but opened at $123.00. Royal Bank of Canada currently has an outperform rating on the stock. […] - 2025-05-07 06:10:42
Investors Purchase Large Volume of Neurocrine Biosciences Put Options (NASDAQ:NBIX)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) was the target of some unusual options trading on Monday. Investors purchased 3,005 put options on the company. This represents an increase of 325% compared to the average volume of 707 put options. Wall Street Analysts Forecast Growth NBIX has been the subject of a number of […] - 2025-05-06 05:10:52
2,425 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Acquired by Marshall Wace LLP
Marshall Wace LLP acquired a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 2,425 shares of the company’s stock, valued at approximately $331,000. A number of other institutional investors have also […] - 2025-05-05 08:03:00
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $158.00 at Canaccord Genuity Group
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective reduced by research analysts at Canaccord Genuity Group from $163.00 to $158.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 47.33% […] - 2025-04-30 06:00:51
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives $161.14 Average Price Target from Analysts
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average 12 month […] - 2025-04-28 06:06:49
Wednesday's ETF with Unusual Volume: FLSP
The Franklin Systematic Style Premia ETF is seeing unusually high volume in afternoon trading Wednesday, with over 1.1 million shares traded versus three month average volume of about 30,000. Shares of FLSP were up about 0.5% on the day. Components of that ETF with the highest - 2025-04-16 16:12:59
Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by Royal Bank of Canada
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by equities research analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a research note issued on Monday, MarketBeat.com reports. The brokerage currently has a $137.00 price objective on the stock, down from their prior price objective of $138.00. […] - 2025-04-16 05:56:51
UBS Group Cuts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $137.00
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price target reduced by UBS Group from $154.00 to $137.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also weighed in on NBIX. Royal Bank of Canada cut their target price […] - 2025-04-07 05:38:48
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives $165.38 Consensus Price Target from Brokerages
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has issued a strong buy recommendation on […] - 2025-04-03 06:06:54
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by American Century Companies Inc.
American Century Companies Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 49.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92,523 shares of the company’s stock after selling 88,727 shares during the period. American Century Companies […] - 2025-04-02 07:54:55
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Corient Private Wealth LLC
Corient Private Wealth LLC grew its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 64.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,927 shares of the company’s stock after purchasing an additional 3,094 shares during the quarter. Corient Private […] - 2025-03-27 09:14:52
Envestnet Portfolio Solutions Inc. Purchases 278 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Envestnet Portfolio Solutions Inc. boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,868 shares of the company’s stock after acquiring an additional 278 shares […] - 2025-03-27 09:14:51
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $184.00 at JPMorgan Chase & Co.
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price target hoisted by JPMorgan Chase & Co. from $183.00 to $184.00 in a report published on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the stock. Several other research analysts also recently commented on NBIX. Barclays increased their price objective on Neurocrine Biosciences from […] - 2025-03-27 07:47:06
Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by StockNews.com
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday. A number of other analysts have also recently issued reports on NBIX. Deutsche Bank Aktiengesellschaft began coverage on shares of Neurocrine Biosciences […] - 2025-03-14 06:12:43
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by M&T Bank Corp
M&T Bank Corp lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 23.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,978 shares of the company’s stock after buying an additional 1,322 shares during the quarter. […] - 2025-03-12 08:19:05
Victory Capital Management Inc. Sells 14,309 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Victory Capital Management Inc. decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 189,896 shares of the company’s stock after selling 14,309 shares during the period. Victory Capital Management […] - 2025-03-11 08:16:52
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 762,557 shares of the company’s stock after buying an additional 15,266 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Neurocrine Biosciences were worth $104,089,000 as […] - 2025-03-10 11:50:03
Smartleaf Asset Management LLC Grows Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Smartleaf Asset Management LLC lifted its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 37.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 538 shares of the company’s stock after purchasing an additional 146 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Neurocrine Biosciences were worth $74,000 as of its […] - 2025-03-10 09:10:55
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Purchased by IFP Advisors Inc
IFP Advisors Inc raised its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,020 shares of the company’s stock after purchasing an additional 137 shares during the period. IFP Advisors Inc’s holdings […] - 2025-03-03 09:35:15
First Horizon Advisors Inc. Has $118,000 Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
First Horizon Advisors Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 14.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 865 shares of the company’s stock after selling 142 shares during the period. First Horizon Advisors Inc.’s holdings in Neurocrine Biosciences were worth $118,000 at the end […] - 2025-02-27 09:05:01
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 42.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,442 shares of the company’s stock after selling 6,148 shares during the period. Vontobel Holding […] - 2025-02-19 09:15:16
Neurocrine Biosciences (NASDAQ:NBIX) Earns Hold Rating from Analysts at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft initiated coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report published on Tuesday, MarketBeat reports. The brokerage issued a hold rating and a $138.00 target price on the stock. NBIX has been the subject of a number of other research reports. Needham & Company LLC restated a “hold” […] - 2025-02-14 09:04:49
State of Alaska Department of Revenue Cuts Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
State of Alaska Department of Revenue cut its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,535 shares of the company’s stock after selling 200 shares during the quarter. State of Alaska Department […] - 2025-02-12 10:44:45
Brokerages Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Price Target at $169.20
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-three research firms that are currently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation, seventeen have issued a buy recommendation and one has issued a strong buy recommendation on […] - 2025-02-12 08:12:57
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $163.00 at Guggenheim
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective reduced by Guggenheim from $165.00 to $163.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the stock. NBIX has been the subject of several other research reports. Royal Bank of Canada decreased their price target on Neurocrine Biosciences from […] - 2025-02-11 07:12:48
Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Down 4.9% After Analyst Downgrade
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report)’s share price traded down 4.9% on Monday after Guggenheim lowered their price target on the stock from $165.00 to $163.00. Guggenheim currently has a buy rating on the stock. Neurocrine Biosciences traded as low as $116.48 and last traded at $116.60. 1,568,535 shares changed hands during mid-day […] - 2025-02-11 06:10:42
Royal Bank of Canada Lowers Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $148.00
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price lowered by Royal Bank of Canada from $154.00 to $148.00 in a report released on Friday,Benzinga reports. The brokerage currently has a sector perform rating on the stock. A number of other research firms have also recently weighed in on NBIX. Canaccord Genuity Group lowered […] - 2025-02-10 16:58:49
Canaccord Genuity Group Cuts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $163.00
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective trimmed by Canaccord Genuity Group from $172.00 to $163.00 in a research note published on Friday,Benzinga reports. The firm currently has a buy rating on the stock. Other analysts have also recently issued research reports about the stock. Raymond James restated an “outperform” rating and […] - 2025-02-10 16:58:47
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Purchased by abrdn plc
abrdn plc boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 14.8% during the fourth quarter, Holdings Channel reports. The firm owned 156,574 shares of the company’s stock after buying an additional 20,150 shares during the quarter. abrdn plc’s holdings in Neurocrine Biosciences were worth $21,372,000 at the end of […] - 2025-02-07 09:28:53

iShares Healthcare Innovation UCITS ETF USD (Acc) NBIX holdings

DateNumber of NBIX Shares HeldBase Market Value of NBIX SharesLocal Market Value of NBIX SharesChange in NBIX Shares HeldChange in NBIX Base ValueCurrent Price per NBIX Share HeldPrevious Price per NBIX Share Held
2025-05-08 (Thursday)112,683USD 13,242,506USD 13,242,506
2025-05-07 (Wednesday)112,683USD 13,703,380NBIX holding increased by 303118USD 13,703,3800USD 303,118 USD 121.61 USD 118.92
2025-05-06 (Tuesday)112,683USD 13,400,262NBIX holding increased by 1033303USD 13,400,2620USD 1,033,303 USD 118.92 USD 109.75
2025-05-05 (Monday)112,683USD 12,366,959NBIX holding increased by 7888USD 12,366,9590USD 7,888 USD 109.75 USD 109.68
2025-05-02 (Friday)112,683USD 12,359,071NBIX holding increased by 348190USD 12,359,0710USD 348,190 USD 109.68 USD 106.59
2025-05-01 (Thursday)112,683USD 12,010,881NBIX holding decreased by -123951USD 12,010,8810USD -123,951 USD 106.59 USD 107.69
2025-04-30 (Wednesday)112,683NBIX holding decreased by -451USD 12,134,832NBIX holding increased by 2342USD 12,134,832-451USD 2,342 USD 107.69 USD 107.24
2025-04-29 (Tuesday)113,134USD 12,132,490NBIX holding increased by 88244USD 12,132,4900USD 88,244 USD 107.24 USD 106.46
2025-04-28 (Monday)113,134NBIX holding decreased by -451USD 12,044,246NBIX holding decreased by -78681USD 12,044,246-451USD -78,681 USD 106.46 USD 106.73
2025-04-25 (Friday)113,585NBIX holding decreased by -451USD 12,122,927NBIX holding increased by 62480USD 12,122,927-451USD 62,480 USD 106.73 USD 105.76
2025-04-24 (Thursday)114,036USD 12,060,447NBIX holding increased by 289651USD 12,060,4470USD 289,651 USD 105.76 USD 103.22
2025-04-23 (Wednesday)114,036USD 11,770,796NBIX holding increased by 168773USD 11,770,7960USD 168,773 USD 103.22 USD 101.74
2025-04-22 (Tuesday)114,036USD 11,602,023NBIX holding increased by 120879USD 11,602,0230USD 120,879 USD 101.74 USD 100.68
2025-04-21 (Monday)114,036USD 11,481,144USD 11,481,144
2025-04-18 (Friday)114,036USD 11,560,970USD 11,560,9700USD 0 USD 101.38 USD 101.38
2025-04-17 (Thursday)114,036USD 11,560,970NBIX holding increased by 145966USD 11,560,9700USD 145,966 USD 101.38 USD 100.1
2025-04-16 (Wednesday)114,036USD 11,415,004NBIX holding increased by 449302USD 11,415,0040USD 449,302 USD 100.1 USD 96.16
2025-04-15 (Tuesday)114,036USD 10,965,702NBIX holding increased by 144826USD 10,965,7020USD 144,826 USD 96.16 USD 94.89
2025-04-14 (Monday)114,036USD 10,820,876USD 10,820,876
2025-04-11 (Friday)114,036NBIX holding decreased by -2712USD 10,362,451NBIX holding decreased by -228928USD 10,362,451-2,712USD -228,928 USD 90.87 USD 90.72
2025-04-10 (Thursday)116,748USD 10,591,379NBIX holding decreased by -532370USD 10,591,3790USD -532,370 USD 90.72 USD 95.28
2025-04-09 (Wednesday)116,748USD 11,123,749NBIX holding increased by 903629USD 11,123,7490USD 903,629 USD 95.28 USD 87.54
2025-04-08 (Tuesday)116,748NBIX holding decreased by -1353USD 10,220,120NBIX holding decreased by -792798USD 10,220,120-1,353USD -792,798 USD 87.54 USD 93.25
2025-04-07 (Monday)118,101NBIX holding increased by 1288USD 11,012,918NBIX holding decreased by -160245USD 11,012,9181,288USD -160,245 USD 93.25 USD 95.65
2025-04-04 (Friday)116,813USD 11,173,163NBIX holding decreased by -1478853USD 11,173,1630USD -1,478,853 USD 95.65 USD 108.31
2025-04-02 (Wednesday)116,813USD 12,652,016NBIX holding increased by 153025USD 12,652,0160USD 153,025 USD 108.31 USD 107
2025-04-01 (Tuesday)116,813USD 12,498,991NBIX holding decreased by -420527USD 12,498,9910USD -420,527 USD 107 USD 110.6
2025-03-31 (Monday)116,813NBIX holding decreased by -886USD 12,919,518NBIX holding decreased by -399301USD 12,919,518-886USD -399,301 USD 110.6 USD 113.16
2025-03-28 (Friday)117,699USD 13,318,819NBIX holding decreased by -98867USD 13,318,8190USD -98,867 USD 113.16 USD 114
2025-03-27 (Thursday)117,699USD 13,417,686NBIX holding decreased by -52965USD 13,417,6860USD -52,965 USD 114 USD 114.45
2025-03-26 (Wednesday)117,699USD 13,470,651NBIX holding decreased by -203619USD 13,470,6510USD -203,619 USD 114.45 USD 116.18
2025-03-25 (Tuesday)117,699USD 13,674,270NBIX holding increased by 68266USD 13,674,2700USD 68,266 USD 116.18 USD 115.6
2025-03-24 (Monday)117,699USD 13,606,004NBIX holding increased by 433132USD 13,606,0040USD 433,132 USD 115.6 USD 111.92
2025-03-21 (Friday)117,699NBIX holding decreased by -886USD 13,172,872NBIX holding increased by 120221USD 13,172,872-886USD 120,221 USD 111.92 USD 110.07
2025-03-20 (Thursday)118,585USD 13,052,651NBIX holding decreased by -28460USD 13,052,6510USD -28,460 USD 110.07 USD 110.31
2025-03-19 (Wednesday)118,585USD 13,081,111NBIX holding increased by 72336USD 13,081,1110USD 72,336 USD 110.31 USD 109.7
2025-03-18 (Tuesday)118,585USD 13,008,775NBIX holding decreased by -213453USD 13,008,7750USD -213,453 USD 109.7 USD 111.5
2025-03-17 (Monday)118,585USD 13,222,228NBIX holding increased by 88939USD 13,222,2280USD 88,939 USD 111.5 USD 110.75
2025-03-14 (Friday)118,585USD 13,133,289NBIX holding increased by 208710USD 13,133,2890USD 208,710 USD 110.75 USD 108.99
2025-03-13 (Thursday)118,585USD 12,924,579NBIX holding decreased by -9487USD 12,924,5790USD -9,487 USD 108.99 USD 109.07
2025-03-12 (Wednesday)118,585NBIX holding decreased by -443USD 12,934,066NBIX holding increased by 171884USD 12,934,066-443USD 171,884 USD 109.07 USD 107.22
2025-03-11 (Tuesday)119,028USD 12,762,182NBIX holding decreased by -434452USD 12,762,1820USD -434,452 USD 107.22 USD 110.87
2025-03-10 (Monday)119,028USD 13,196,634NBIX holding decreased by -258291USD 13,196,6340USD -258,291 USD 110.87 USD 113.04
2025-03-07 (Friday)119,028USD 13,454,925NBIX holding increased by 45231USD 13,454,9250USD 45,231 USD 113.04 USD 112.66
2025-03-06 (Thursday)119,028USD 13,409,694NBIX holding decreased by -141644USD 13,409,6940USD -141,644 USD 112.66 USD 113.85
2025-03-05 (Wednesday)119,028USD 13,551,338NBIX holding increased by 88081USD 13,551,3380USD 88,081 USD 113.85 USD 113.11
2025-03-04 (Tuesday)119,028USD 13,463,257NBIX holding decreased by -163068USD 13,463,2570USD -163,068 USD 113.11 USD 114.48
2025-03-03 (Monday)119,028USD 13,626,325NBIX holding decreased by -504679USD 13,626,3250USD -504,679 USD 114.48 USD 118.72
2025-02-28 (Friday)119,028NBIX holding decreased by -443USD 14,131,004NBIX holding increased by 91967USD 14,131,004-443USD 91,967 USD 118.72 USD 117.51
2025-02-27 (Thursday)119,471USD 14,039,037NBIX holding decreased by -9558USD 14,039,0370USD -9,558 USD 117.51 USD 117.59
2025-02-26 (Wednesday)119,471USD 14,048,595NBIX holding increased by 201906USD 14,048,5950USD 201,906 USD 117.59 USD 115.9
2025-02-25 (Tuesday)119,471NBIX holding increased by 443USD 13,846,689NBIX holding decreased by -330736USD 13,846,689443USD -330,736 USD 115.9 USD 119.11
2025-02-24 (Monday)119,028USD 14,177,425NBIX holding decreased by -188064USD 14,177,4250USD -188,064 USD 119.11 USD 120.69
2025-02-21 (Friday)119,028USD 14,365,489NBIX holding increased by 545148USD 14,365,4890USD 545,148 USD 120.69 USD 116.11
2025-02-20 (Thursday)119,028NBIX holding decreased by -443USD 13,820,341NBIX holding increased by 169585USD 13,820,341-443USD 169,585 USD 116.11 USD 114.26
2025-02-19 (Wednesday)119,471NBIX holding increased by 886USD 13,650,756NBIX holding increased by 135624USD 13,650,756886USD 135,624 USD 114.26 USD 113.97
2025-02-18 (Tuesday)118,585NBIX holding increased by 443USD 13,515,132NBIX holding decreased by -73561USD 13,515,132443USD -73,561 USD 113.97 USD 115.02
2025-02-17 (Monday)118,142USD 13,588,693USD 13,588,6930USD 0 USD 115.02 USD 115.02
2025-02-14 (Friday)118,142USD 13,588,693NBIX holding decreased by -218563USD 13,588,6930USD -218,563 USD 115.02 USD 116.87
2025-02-13 (Thursday)118,142USD 13,807,256NBIX holding decreased by -36624USD 13,807,2560USD -36,624 USD 116.87 USD 117.18
2025-02-12 (Wednesday)118,142USD 13,843,880NBIX holding increased by 38987USD 13,843,8800USD 38,987 USD 117.18 USD 116.85
2025-02-11 (Tuesday)118,142USD 13,804,893NBIX holding decreased by -230967USD 13,804,8930USD -230,967 USD 116.85 USD 118.805
2025-02-10 (Monday)118,142USD 14,035,860NBIX holding decreased by -450712USD 14,035,8600USD -450,712 USD 118.805 USD 122.62
2025-02-07 (Friday)118,142USD 14,486,572NBIX holding decreased by -3294980USD 14,486,5720USD -3,294,980 USD 122.62 USD 150.51
2025-02-06 (Thursday)118,142USD 17,781,552NBIX holding decreased by -81518USD 17,781,5520USD -81,518 USD 150.51 USD 151.2
2025-02-05 (Wednesday)118,142USD 17,863,070NBIX holding decreased by -144134USD 17,863,0700USD -144,134 USD 151.2 USD 152.42
2025-02-04 (Tuesday)118,142USD 18,007,204NBIX holding increased by 274090USD 18,007,2040USD 274,090 USD 152.42 USD 150.1
2025-02-03 (Monday)118,142USD 17,733,114NBIX holding decreased by -203204USD 17,733,1140USD -203,204 USD 150.1 USD 151.82
2025-01-31 (Friday)118,142USD 17,936,318NBIX holding decreased by -173669USD 17,936,3180USD -173,669 USD 151.82 USD 153.29
2025-01-30 (Thursday)118,142USD 18,109,987NBIX holding increased by 308350USD 18,109,9870USD 308,350 USD 153.29 USD 150.68
2025-01-29 (Wednesday)118,142USD 17,801,637NBIX holding decreased by -3544USD 17,801,6370USD -3,544 USD 150.68 USD 150.71
2025-01-28 (Tuesday)118,142USD 17,805,181NBIX holding increased by 297718USD 17,805,1810USD 297,718 USD 150.71 USD 148.19
2025-01-27 (Monday)118,142USD 17,507,463NBIX holding decreased by -63797USD 17,507,4630USD -63,797 USD 148.19 USD 148.73
2025-01-24 (Friday)118,142USD 17,571,260NBIX holding increased by 135864USD 17,571,2600USD 135,864 USD 148.73 USD 147.58
2025-01-23 (Thursday)118,142USD 17,435,396NBIX holding increased by 96876USD 17,435,3960USD 96,876 USD 147.58 USD 146.76
2025-01-22 (Wednesday)118,142USD 17,338,520USD 17,338,520
2025-01-21 (Tuesday)118,585USD 17,299,180USD 17,299,180
2025-01-20 (Monday)118,585USD 16,988,487USD 16,988,487
2025-01-17 (Friday)118,585USD 16,988,487USD 16,988,487
2025-01-16 (Thursday)119,028USD 16,892,454USD 16,892,454
2025-01-15 (Wednesday)119,028USD 16,968,632USD 16,968,632
2025-01-14 (Tuesday)119,028USD 16,605,596USD 16,605,596
2025-01-13 (Monday)119,028USD 17,024,575USD 17,024,575
2025-01-10 (Friday)119,028USD 16,771,045USD 16,771,045
2025-01-09 (Thursday)119,028USD 16,510,374USD 16,510,374
2025-01-09 (Thursday)119,028USD 16,510,374USD 16,510,374
2025-01-09 (Thursday)119,028USD 16,510,374USD 16,510,374
2025-01-08 (Wednesday)119,028USD 16,510,374USD 16,510,374
2025-01-08 (Wednesday)119,028USD 16,510,374USD 16,510,374
2025-01-08 (Wednesday)119,028USD 16,510,374USD 16,510,374
2025-01-02 (Thursday)119,028USD 16,409,200NBIX holding increased by 95222USD 16,409,2000USD 95,222 USD 137.86 USD 137.06
2024-12-30 (Monday)119,028NBIX holding increased by 1434USD 16,313,978NBIX holding increased by 1149056USD 16,313,9781,434USD 1,149,056 USD 137.06 USD 128.96
2024-12-10 (Tuesday)117,594USD 15,164,922NBIX holding decreased by -18815USD 15,164,9220USD -18,815 USD 128.96 USD 129.12
2024-12-09 (Monday)117,594USD 15,183,737NBIX holding increased by 115242USD 15,183,7370USD 115,242 USD 129.12 USD 128.14
2024-12-06 (Friday)117,594NBIX holding decreased by -434USD 15,068,495NBIX holding increased by 147395USD 15,068,495-434USD 147,395 USD 128.14 USD 126.42
2024-12-05 (Thursday)118,028USD 14,921,100NBIX holding decreased by -155797USD 14,921,1000USD -155,797 USD 126.42 USD 127.74
2024-12-04 (Wednesday)118,028NBIX holding decreased by -434USD 15,076,897NBIX holding increased by 217024USD 15,076,897-434USD 217,024 USD 127.74 USD 125.44
2024-12-03 (Tuesday)118,462NBIX holding decreased by -868USD 14,859,873NBIX holding decreased by -162581USD 14,859,873-868USD -162,581 USD 125.44 USD 125.89
2024-12-02 (Monday)119,330USD 15,022,454NBIX holding decreased by -102624USD 15,022,4540USD -102,624 USD 125.89 USD 126.75
2024-11-29 (Friday)119,330USD 15,125,078NBIX holding increased by 19093USD 15,125,0780USD 19,093 USD 126.75 USD 126.59
2024-11-28 (Thursday)119,330USD 15,105,985USD 15,105,9850USD 0 USD 126.59 USD 126.59
2024-11-27 (Wednesday)119,330USD 15,105,985NBIX holding decreased by -157515USD 15,105,9850USD -157,515 USD 126.59 USD 127.91
2024-11-26 (Tuesday)119,330USD 15,263,500NBIX holding increased by 95464USD 15,263,5000USD 95,464 USD 127.91 USD 127.11
2024-11-25 (Monday)119,330USD 15,168,036NBIX holding increased by 174221USD 15,168,0360USD 174,221 USD 127.11 USD 125.65
2024-11-22 (Friday)119,330USD 14,993,815NBIX holding increased by 77565USD 14,993,8150USD 77,565 USD 125.65 USD 125
2024-11-21 (Thursday)119,330NBIX holding decreased by -434USD 14,916,250NBIX holding increased by 150546USD 14,916,250-434USD 150,546 USD 125 USD 123.29
2024-11-20 (Wednesday)119,764NBIX holding decreased by -433USD 14,765,704NBIX holding increased by 446635USD 14,765,704-433USD 446,635 USD 123.29 USD 119.13
2024-11-19 (Tuesday)120,197NBIX holding increased by 267USD 14,319,069NBIX holding increased by 212902USD 14,319,069267USD 212,902 USD 119.13 USD 117.62
2024-11-18 (Monday)119,930NBIX holding decreased by -1724USD 14,106,167NBIX holding decreased by -1345108USD 14,106,167-1,724USD -1,345,108 USD 117.62 USD 127.01
2024-11-12 (Tuesday)121,654NBIX holding decreased by -431USD 15,451,275NBIX holding increased by 100307USD 15,451,275-431USD 100,307 USD 127.01 USD 125.74
2024-11-08 (Friday)122,085USD 15,350,968NBIX holding increased by 214870USD 15,350,9680USD 214,870 USD 125.74 USD 123.98
2024-11-07 (Thursday)122,085NBIX holding decreased by -431USD 15,136,098NBIX holding decreased by -215157USD 15,136,098-431USD -215,157 USD 123.98 USD 125.3
2024-11-06 (Wednesday)122,516USD 15,351,255NBIX holding increased by 461886USD 15,351,2550USD 461,886 USD 125.3 USD 121.53
2024-11-05 (Tuesday)122,516NBIX holding decreased by -862USD 14,889,369NBIX holding increased by 18619USD 14,889,369-862USD 18,619 USD 121.53 USD 120.53
2024-11-04 (Monday)123,378USD 14,870,750NBIX holding decreased by -207275USD 14,870,7500USD -207,275 USD 120.53 USD 122.21
2024-11-01 (Friday)123,378USD 15,078,025NBIX holding increased by 239353USD 15,078,0250USD 239,353 USD 122.21 USD 120.27
2024-10-31 (Thursday)123,378USD 14,838,672NBIX holding decreased by -500915USD 14,838,6720USD -500,915 USD 120.27 USD 124.33
2024-10-30 (Wednesday)123,378USD 15,339,587NBIX holding increased by 1004297USD 15,339,5870USD 1,004,297 USD 124.33 USD 116.19
2024-10-29 (Tuesday)123,378USD 14,335,290NBIX holding decreased by -1234USD 14,335,2900USD -1,234 USD 116.19 USD 116.2
2024-10-28 (Monday)123,378NBIX holding decreased by -431USD 14,336,524NBIX holding decreased by -35225USD 14,336,524-431USD -35,225 USD 116.2 USD 116.08
2024-10-25 (Friday)123,809USD 14,371,749NBIX holding increased by 69333USD 14,371,7490USD 69,333 USD 116.08 USD 115.52
2024-10-24 (Thursday)123,809USD 14,302,416NBIX holding increased by 54476USD 14,302,4160USD 54,476 USD 115.52 USD 115.08
2024-10-23 (Wednesday)123,809USD 14,247,940NBIX holding decreased by -210475USD 14,247,9400USD -210,475 USD 115.08 USD 116.78
2024-10-22 (Tuesday)123,809USD 14,458,415NBIX holding increased by 26000USD 14,458,4150USD 26,000 USD 116.78 USD 116.57
2024-10-21 (Monday)123,809USD 14,432,415NBIX holding decreased by -178285USD 14,432,4150USD -178,285 USD 116.57 USD 118.01
2024-10-18 (Friday)123,809USD 14,610,700USD 14,610,700
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NBIX by Blackrock for IE00BYZK4776

Show aggregate share trades of NBIX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-30SELL-451 107.690* 118.98 Profit of 53,662 on sale
2025-04-28SELL-451 106.460* 119.23 Profit of 53,772 on sale
2025-04-25SELL-451 106.730* 119.36 Profit of 53,830 on sale
2025-04-11SELL-2,712 90.870* 121.07 Profit of 328,343 on sale
2025-04-08SELL-1,353 87.540* 122.10 Profit of 165,203 on sale
2025-04-07BUY1,288 93.250* 122.44
2025-03-31SELL-886 110.600* 123.27 Profit of 109,215 on sale
2025-03-21SELL-886 111.920* 123.98 Profit of 109,848 on sale
2025-03-12SELL-443 109.070* 125.40 Profit of 55,550 on sale
2025-02-28SELL-443 118.720* 127.02 Profit of 56,271 on sale
2025-02-25BUY443 115.900* 127.54
2025-02-20SELL-443 116.110* 128.03 Profit of 56,715 on sale
2025-02-19BUY886 114.260* 128.28
2025-02-18BUY443 113.970* 128.55
2024-12-30BUY1,434 137.060* 123.05
2024-12-06SELL-434 128.140* 122.48 Profit of 53,157 on sale
2024-12-04SELL-434 127.740* 122.15 Profit of 53,014 on sale
2024-12-03SELL-868 125.440* 122.03 Profit of 105,923 on sale
2024-11-21SELL-434 125.000* 120.18 Profit of 52,157 on sale
2024-11-20SELL-433 123.290* 120.00 Profit of 51,962 on sale
2024-11-19BUY267 119.130* 120.06
2024-11-18SELL-1,724 117.620* 120.21 Profit of 207,238 on sale
2024-11-12SELL-431 127.010* 119.75 Profit of 51,614 on sale
2024-11-07SELL-431 123.980* 118.97 Profit of 51,275 on sale
2024-11-05SELL-862 121.530* 118.16 Profit of 101,854 on sale
2024-10-28SELL-431 116.200* 116.01 Profit of 49,999 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NBIX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-09365,53273523,04569.9%
2025-05-08627,9212441,175,09753.4%
2025-05-07713,4692,7221,117,87463.8%
2025-05-061,400,8677,0302,532,76355.3%
2025-05-05296,619121644,95446.0%
2025-05-02365,2402,717878,86541.6%
2025-05-01334,9091,718414,53880.8%
2025-04-30184,71978452,37340.8%
2025-04-29188,8452,237268,76570.3%
2025-04-28240,71657398,17760.5%
2025-04-25383,4342,042564,85767.9%
2025-04-24365,832195488,33974.9%
2025-04-23458,700190910,60550.4%
2025-04-22348,645324835,21641.7%
2025-04-21395,831361658,51460.1%
2025-04-17457,575124678,13267.5%
2025-04-16965,3531681,358,85571.0%
2025-04-15379,4271,823668,18356.8%
2025-04-14450,911249754,05659.8%
2025-04-11333,520203674,09149.5%
2025-04-10472,023315628,44075.1%
2025-04-09602,3303041,006,29959.9%
2025-04-08436,875162790,24955.3%
2025-04-07674,3984211,003,46367.2%
2025-04-04539,933385892,09460.5%
2025-04-03376,70499768,73849.0%
2025-04-02234,959215551,49842.6%
2025-04-01280,10130636,76344.0%
2025-03-31216,215308411,40852.6%
2025-03-28265,01180324,52281.7%
2025-03-27234,01141308,20075.9%
2025-03-26305,665215394,49577.5%
2025-03-25314,22286480,62565.4%
2025-03-24273,4171,005391,30669.9%
2025-03-21332,9586436,52176.3%
2025-03-20210,69223342,21661.6%
2025-03-19175,55972288,22360.9%
2025-03-18202,506165360,59356.2%
2025-03-17212,919102305,43569.7%
2025-03-14163,94214,843330,86749.5%
2025-03-13178,6727,541288,43761.9%
2025-03-12201,638171467,32343.1%
2025-03-11231,365248763,18830.3%
2025-03-10214,090558359,05959.6%
2025-03-07251,5315,013472,74353.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.